Allergy Therapeutics Market Cap

Allergy Therapeutics has a market cap or net worth of 664.92 million as of April 16, 2026. Its market cap has increased by 116.28% in one year.

Market Cap

664.92M

Enterprise Value

681.58M

Revenue

57.29M

Ranking

n/a

PE Ratio

n/a

Stock Price

10.40

Market Cap Chart

Since October 11, 2004, Allergy Therapeutics's market cap has increased from 30.57M to 664.92M, an increase of 2,075.10%. That is a compound annual growth rate of 15.38%.

Market Cap History

Date	Market Cap	% Change
Apr 15, 2026	690.25M	2.17%
Dec 31, 2025	675.56M	118.05%
Dec 31, 2024	309.82M	160.00%
Dec 29, 2023	119.16M	180.75%
Dec 30, 2022	42.44M	-79.49%
Dec 31, 2021	206.98M	94.57%
Dec 31, 2020	Upgrade Pro	Upgrade Pro
Dec 31, 2019	Upgrade Pro	Upgrade Pro
Dec 31, 2018	Upgrade Pro	Upgrade Pro
Dec 29, 2017	Upgrade Pro	Upgrade Pro
Dec 30, 2016	Upgrade Pro	Upgrade Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Haleon	31.48B
Hikma Pharmaceuticals	2.91B
HUTCHMED (China)	1.89B
Animalcare Group	170.54M
Shield Therapeutics	99.90M
Venture Life Group	81.62M
ECO Animal Health Group	70.13M
Provexis	24.40M

Market Cap Rankings